Chapter 10 Screening for Disease

Slides:



Advertisements
Similar presentations
©2011 Elsevier, Inc. Molecular Tools and Infectious Disease Epidemiology Betsy Foxman Chapter 8 Determining the Reliability and Validity and Interpretation.
Advertisements

Validity and Reliability of Analytical Tests. Analytical Tests include both: Screening Tests Diagnostic Tests.
Lecture 3 Validity of screening and diagnostic tests
SCREENING CHP400: Community Health Program-lI Mohamed M. B. Alnoor
Evaluating Classifiers
The Research Consumer Evaluates Measurement Reliability and Validity
TESTING A TEST Ian McDowell Department of Epidemiology & Community Medicine November, 2004.
Evaluation of segmentation. Example Reference standard & segmentation.
Module 6 “Normal Values”: How are Normal Reference Ranges Established?
Sensitivity, Specificity and ROC Curve Analysis.
SCREENING FOR DISEASE Nigel Paneth. THREE KEY MEASURES OF VALIDITY 1.SENSITIVITY 2.SPECIFICITY 3.PREDICTIVE VALUE.
The University of Texas at Austin, CS 395T, Spring 2008, Prof. William H. Press 1 Computational Statistics with Application to Bioinformatics Prof. William.
GerstmanChapter 41 Epidemiology Kept Simple Chapter 4 Screening for Disease.
Concept of Measurement
Epidemiology Kept Simple Chapter 4 Screening for Disease.
Darlene Goldstein 29 January 2003 Receiver Operating Characteristic Methodology.
Jeremy Wyatt Thanks to Gavin Brown
Baye’s Rule and Medical Screening Tests. Baye’s Rule Baye’s Rule is used in medicine and epidemiology to calculate the probability that an individual.
IE486 Work Analysis & Design II Lab 4 – Upper Limb Assessment Supplementary Notes on Evaluation of Analysis Tools March 23, 2007 Vincent G. Duffy, IE &
Screening revision! By Ilona Blee. What are some UK Screening programmes?  Antenatal & newborn screening  Newborn Blood Spot  Newborn Hearing Screening.
Principles of Epidemiology Lecture 12 Dona Schneider, PhD, MPH, FACE
Screening for Disease Guan Peng Department of Epidemiology School of Public Health, CMU.
(Medical) Diagnostic Testing. The situation Patient presents with symptoms, and is suspected of having some disease. Patient either has the disease or.
What is Screening? Basic Public Health Concepts Sheila West, Ph.D. El Maghraby Professor of Ophthalmology Wilmer Eye Institute Johns Hopkins University.
Screening Test for Occult Cancer 100 patients with occult cancer: 95 have "x" in their blood 100 patients without occult cancer: 95 do not have "x" in.
Lecture 4: Assessing Diagnostic and Screening Tests
Basic statistics 11/09/13.
Diagnostic Testing Ethan Cowan, MD, MS Department of Emergency Medicine Jacobi Medical Center Department of Epidemiology and Population Health Albert Einstein.
Division of Population Health Sciences Royal College of Surgeons in Ireland Coláiste Ríoga na Máinleá in Éirinn Indices of Performances of CPRs Nicola.
Sensitivity Sensitivity answers the following question: If a person has a disease, how often will the test be positive (true positive rate)? i.e.: if the.
Evaluation of Diagnostic Tests
CpSc 810: Machine Learning Evaluation of Classifier.
CHP400: Community Health Program-lI Mohamed M. B. Alnoor Muna M H Diab SCREENING.
Sensitivity & Specificity Sam Thomson 8/12/10. Sensitivity Proportion of people with the condition who have a positive test result Proportion of people.
1 Epidemiological Measures I Screening for Disease.
CT image testing. What is a CT image? CT= computed tomography CT= computed tomography Examines a person in “slices” Examines a person in “slices” Creates.
Statistical test for Non continuous variables. Dr L.M.M. Nunn.
Evidence-Based Medicine Diagnosis Component 2 / Unit 5 1 Health IT Workforce Curriculum Version 1.0 /Fall 2010.
SCREENING Dr. Aliya Hisam Community Medicine Dept. Army Medical College, RWP.
Evaluating Results of Learning Blaž Zupan
TESTING A TEST Ian McDowell Department of Epidemiology & Community Medicine January 2008.
Screening of diseases Dr Zhian S Ramzi Screening 1 Dr. Zhian S Ramzi.
HSS4303B – Intro to Epidemiology Feb 8, Agreement.
Diagnostic Tests Afshin Ostovar Bushehr University of Medical Sciences Bushehr, /7/20151.
1 Wrap up SCREENING TESTS. 2 Screening test The basic tool of a screening program easy to use, rapid and inexpensive. 1.2.
Predictive values prevalence CK and acute myocardial infarction –sensitivity 70% –specificity 80% –prevalence - 40% –prevalence - 20% –PPV and NPV.
Diagnostic Tests Studies 87/3/2 “How to read a paper” workshop Kamran Yazdani, MD MPH.
Fall 2002Biostat Probability Probability - meaning 1) classical 2) frequentist 3) subjective (personal) Sample space, events Mutually exclusive,
Screening.  “...the identification of unrecognized disease or defect by the application of tests, examinations or other procedures...”  “...sort out.
Evidence based medicine Diagnostic tests Ross Lawrenson.
1 Medical Epidemiology Interpreting Medical Tests and Other Evidence.
Professor William H. Press, Department of Computer Science, the University of Texas at Austin1 Opinionated in Statistics by Bill Press Lessons #50 Binary.
Diagnosis Examination(MMSE) in detecting dementia among elderly patients living in the community. Excel.
Handbook for Health Care Research, Second Edition Chapter 11 © 2010 Jones and Bartlett Publishers, LLC CHAPTER 11 Statistical Methods for Nominal Measures.
SCREENING FOR DISEASE. Learning Objectives Definition of screening; Principles of Screening.
CHAPTER 3 Key Principles of Statistical Inference.
Critical Appraisal Course for Emergency Medicine Trainees Module 5 Evaluation of a Diagnostic Test.
دکتر حمیدرضا صابری
CHP400: Community Health Program-lI Mohamed M. B. Alnoor Muna M H Diab SCREENING.
Performance of a diagnostic test Tunisia, 31 Oct 2014
Probability and Statistics
Class session 7 Screening, validity, reliability
What is Screening? Basic Public Health Concepts Sheila West, Ph.D.
کاربرد آمار در آزمایشگاه
Diagnosis II Dr. Brent E. Faught, Ph.D. Assistant Professor
What is Screening? Basic Public Health Concepts Sheila West, Ph.D.
Is a Positive Developmental-Behavioral Screening Score Sufficient to Justify Referral? A Review of Evidence and Theory  R. Christopher Sheldrick, PhD,
The receiver operating characteristic (ROC) curve
Patricia Butterfield & Naomi Chaytor October 18th, 2017
Evidence Based Diagnosis
Presentation transcript:

Chapter 10 Screening for Disease 4/24/2017 Chapter 10 Screening for Disease Screening for Disease

Terminology Reliability ≡ agreement of ratings/diagnoses, “reproducibility” Inter-rater reliability ≡ agreement between two independent raters Intra-rater reliability ≡ agreement of the same rater with him/herself Validity ≡ ability to discriminate without error Accuracy ≡ a combination of reliability and validity

Inter-Rater Reliability Two independent raters Cross-tabulate Observed proportion in agreement NOT adequate because a certain amount of agreement is due to chance Rater B Rater A + − Total a b g1 c d g2 f1 f2 N

Kappa (κ) [Agreement corrected for chance] Rater B Rater A + − Total a

κ Benchmarks

Example 1: Flip two coins To what extent are results reproducible? Toss B Toss A Heads Tails Total 25 50 100

To what extent are these diagnoses reproducible? Example 2 To what extent are these diagnoses reproducible? Rater B Rater A + − Total 20 4 24 5 71 76 25 75 100 “substantial” agreement

§10.3 Validity Compare screening test results to a gold standard (“definitive diagnosis”) Each patient is classified as either true positive (TP), true negative (TN), false positive (FP), or false negative (FN) Test D+ D− Total T+ TP FP TP+FP T− FN TN FN+TN TP+FN FP+TN N

SEN ≡ proportion of cases that test positive Sensitivity Test D+ D− Total T+ TP FP TP+FP T− FN TN FN+TN TP+FN FP+TN N SEN ≡ proportion of cases that test positive

SPEC ≡ proportion of noncases that test negative Specificity Test D+ D− Total T+ TP FP TP+FP T− FN TN FN+TN TP+FN FP+TN N SPEC ≡ proportion of noncases that test negative

Predictive Value Positive Test D+ D− Total T+ TP FP TP+FP T− FN TN FN+TN TP+FN FP+TN N PVP ≡ proportion of positive tests that are true cases

Predictive Value Negative Test D+ D− Total T+ TP FP TP+FP T− FN TN FN+TN TP+FN FP+TN N PVN ≡ proportion of negative tests that are true non-cases

Prevalence [True] prevalence = (TP + FN) / N Test D+ D− Total T+ TP FP TP+FP T− FN TN FN+TN TP+FN FP+TN N [True] prevalence = (TP + FN) / N Apparent prevalence = (TP + FP) / N

Conditional Probability Notation Pr(A|B) ≡ “the probability of A given B” For example Pr(T+|D+) ≡ “probability test positive given disease positive” = SENsitivity SPEC ≡ Pr(T−|D−) PVP = Pr(D+|T+) PVN= Pr(D−|T−)

Example Low Prevalence Population Conditions: N = 1,000,000; Prevalence = .001 D+ D− Total T+ T− 1000 1,000,000 Prevalence = (those with disease) / N Therefore: (Those with disease) = Prevalence × N = .001× 1,000,000 = 1000

Example: Low Prevalence Population Number of non-cases, i.e., TN + FP D+ D− Total T+ T− 1000 999,000 1,000,000 1,000,000 – 1,000 = 999,000

Example: Low Prevalence Population Assume test SENsitivity = .99, i.e., Test will pick up 99% of those with disease D+ D− Total T+ 990 T− 1000 TP = SEN × (those with disease) = 0.99 × 1000 = 990

Example: Low Prevalence Population It follows that: D+ D− Total T+ 990 T− 10 1000 FN = 1000 – 990 = 10

Example: Low Prevalence Population Suppose test SPECificity = .99 i.e., it will correctly identify 99% of the noncases D+ D− Total T+ T− 989,010 999,000 TN = SPEC × (those without disease) = 0.99 × 999,000 = 989,010

Example: Low Prevalence Population It follows that: D+ D− Total T+ 9,990 T− 989,010 999,000 FPs = 999,000 – 989,010 = 9,900

Example: Low Prevalence Population It follows that the Predictive Value Positive is : D+ D− Total T+ 990 9,990 10,980 T− 10 989,010 989,020 1000 999,000 1,000,000 PVPT = TP / (TP + FP) = 990 / 10,980 = 0.090 Strikingly low PVP!

Example: Low Prevalence Population It follows that the Predictive Value Negative is: D+ D− Total T+ 990 9,990 10,980 T− 10 989,010 989,020 1000 999,000 1,000,000 PVNT= TN / (all those who test negative) = 989010 / 989020 = .9999

Example: High prevalence population Same test parameters but used in population with true prevalence of .10 D+ D− Total T+ 99,000 9,000 108,000 T− 1,000 891,000 892,000 100,000 900,000 1,000,000 Prev = 100000 / 1,000,000 = 0.10 SEN = 99000 / 100,000 = 0.99 SPEC = 891,000 / 900,000 = 0.99

Example: High prevalence population An HIV screening test is used in one million people. Prevalence in population is now 10%. SEN and SPEC are again 99%. D+ D− Total T+ 99,000 9,000 108,000 T− 1,000 891,000 892,000 100,000 900,000 1,000,000 Prevalence = 100000 / 1,000,000 = 0.10 PVP = 99,000 / 108,000 = 0.92 PVN = 891,000 / 892,000 = 0.9989

PVPT and Prevalence As PREValence goes down, PVPT is affected Figure shows relation between PVP, PREV, & SPEC (test SEN = constant .99)

Screening Strategy First stage  high SENS (don’t want to miss cases) Second stage  high SPEC (sort out false positives from true positives)

Selecting a Cutoff Point There is often an overlap in test results for diseased and non-diseased population Sensitivity and specificity are influenced by the chosen cutoff point used to determine positive results Example: Immunofluorescence test for HIV based on optical density ratio (next slide)

High sensitivity and low specificity Low Cutoff High sensitivity and low specificity

Low sensitivity and high specificity High Cutoff Low sensitivity and high specificity

moderate sensitivity & moderate specificity Intermediate Cutoff moderate sensitivity & moderate specificity